Log In
BCIQ
Print this Print this
 

Minocycline Periodontal Therapeutic System (MPTS), minocycline

Also known as: Arestin

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionDry powder formulation of minocycline broad-spectrum antibiotic in bioresorbable microspheres
Molecular Target Ribosomal 30S subunit
Mechanism of ActionProkaryotic protein synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPeriodontitis
Indication DetailsTreat adult periodontitis; Treat chronic periodontitis; Treat periodontal disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$426.0M

$312.0M

$114.0M


 Deals Details
Get a free BioCentury trial today